Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001641172-25-014710
Filing Date
2025-06-11
Accepted
2025-06-11 16:15:32
Documents
1
Effectiveness Date
2025-06-11
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11873
  Complete submission text file 0001641172-25-014710.txt   13028
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-548685 | Film No.: 251040188
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)